Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly  Settings
SLXP [NASD]
Salix Pharmaceuticals Ltd.
Healthcare - Drug Related Products - USA
financial highlights | statements
Index- P/E- EPS (ttm)-0.98 Insider Own3.17% Shs Outstand49.34M Perf Week-4.90%
Market Cap1.33B Forward P/E149.83 EPS next Y0.18 Insider Trans-43.82% Shs Float47.78M Perf Month-3.64%
Income-47.13M PEG- EPS next Q-0.14 Inst Own95.00% Short Float10.23% Perf Quarter28.80%
Sales223.24M P/S5.96 EPS this Y-681.18% Inst Trans8.49% Short Ratio5.78 Perf Half Y112.03%
Book/sh4.82 P/B5.60 EPS next Y119.10% ROA-11.62% Target Price36.75 Perf Year180.35%
Cash/sh1.40 P/C19.26 EPS next 5Y42.50% ROE-18.97% 52W Range6.14 - 29.91 Perf YTD6.22%
Dividend- P/FCF- EPS past 5Y23.53% ROI-14.34% 52W High-9.83% Beta0.80
Dividend %- Quick Ratio1.73 Sales past 5Y26.22% Gross Margin75.32% 52W Low339.25% ATR0.98
Employees280 Current Ratio1.98 Sales Q/Q53.15% Oper. Margin-19.56% RSI (14)47.25 Volatility3.75% 3.59%
OptionableYes Debt/Eq0.27 EPS Q/Q-32.07% Profit Margin-21.11% Rel Volume0.44 Prev Close27.10
ShortableYes LT Debt/Eq0.26 EarningsNov 09 AMC Payout- Avg Volume845.79K Price26.97
Recom1.70 SMA20-4.10% SMA503.95% SMA20054.72% Volume368,050 Change-0.48%
28-Jan-10 02:30PM  The Biggest Growth Stocks in Health Care at Minyanville.com
26-Jan-10 02:10PM  Bulls On Board For A Big Run From Salix at Forbes.com
01:51PM  Salix upgraded ahead of FDA's Xifaxan decision AP
01:10AM  Salix Pharm upgraded by Oppenheimer Briefing.com
08-Jan-10 09:22PM  Lightning Round: Boeing, Cadbury, Fifth Third Bancorp and More at CNBC
05-Jan-10 08:46AM  Early-Market Movers: Tenet Healthcare, Las Vegas Sands at Fox Business +6.07%
23-Dec-09 06:05PM  Salix slapped with lawsuit over OsmoPrep at bizjournals.com
04:32PM  InPlay: Salix Pharm: Suits commenced against maker of prescription cleansing drug Briefing.com
04:31PM  Suits Commenced Against Maker of Prescription Cleansing Drug PR Newswire
16-Dec-09 11:52AM  Salix to File for IBS Indication Zacks.com
11-Dec-09 01:05PM  Salix, FDA discuss new drug application at bizjournals.com
10-Dec-09 04:34PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online
09:31AM  Salix Pharmaceuticals Reports Concurrence with FDA on Content and Format of the Pending Rifaximin NDA in the Treatment of Non-Constipation Irritable Bowel Syndrome Business Wire
24-Nov-09 02:43PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:00AM  Salix Pharmaceuticals to Present at Piper Jaffray Conference Business Wire
23-Nov-09 02:45PM  Salix Pharmaceuticals completes stock offering AP
01:12PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi EDGAR Online
01:05PM  Salix pockets $128.2M in stock offering at bizjournals.com
11:50AM  Salix Pharmaceuticals, Ltd. Completes Sale of 6.325 Million Shares of Common Stock Business Wire
19-Nov-09 06:01AM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial Statements and Exhibi EDGAR Online +7.23%
18-Nov-09 03:21PM  Build Your Fortune With These Winners at Motley Fool
11:18AM  Salix offering 5.5 million shares of stock AP
09:09AM  Salix Pharmaceuticals, Ltd. Announces Pricing of a Public Offering of Common Stock Business Wire
13-Nov-09 09:05AM  SALIX PHARMACEUTICALS LTD Financials EDGAR Online Financials
11-Nov-09 03:56PM  Salix Beats on Xifaxan Strength Zacks.com
10-Nov-09 07:05AM  Salix smacks Street with strong 3Q report at bizjournals.com -5.01%
09-Nov-09 10:00PM  Salix Pharmaceuticals Ltd Q3 2009 Earnings Call Transcript at Seeking Alpha
06:21PM  Salix 3Q loss widens on higher costs AP
05:00PM  Salix Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
04:47PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
04:37PM  UPDATE - Salix posts narrower-than-expected Q3 loss at Reuters
04:32PM  SALIX PHARMACEUTICALS LTD Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Salix Pharmaceuticals Reports 3Q2009 Results Business Wire
07:07AM  Q3 2009 Salix Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
05-Nov-09 06:05AM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online +5.08%
04-Nov-09 07:01AM  Salix Pharmaceuticals to Host Analyst Day on November 18 Business Wire
07:00AM  Salix Pharmaceuticals to Present at Credit Suisse Conference Business Wire
03-Nov-09 10:09AM  Salix Pharmaceuticals Secures Additional Intellecutual Property Relating to Rifaximin Business Wire +5.21%
02-Nov-09 05:31PM  Award Winning Piper Jaffrey Analyst Sees Transkaryotic Therapeutics Acquisition Paying Off For Shire With Early 2010 Approval Of Velaglucerase Wall Street Transcript
07:00AM  Salix Pharmaceuticals Reviews American Association for the Study of Liver Diseases Annual Meeting Business Wire
30-Oct-09 02:42PM  Bearish MACD for Salix Zacks.com
27-Oct-09 05:21PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
26-Oct-09 11:00AM  Salix Pharmaceuticals Previews American College of Gastroenterology 2009 Annual Scientific Meeting Business Wire
07:00AM  Salix Pharmaceuticals Announces 3Q2009 Financial Results Conference Call and Webcast Business Wire
07-Oct-09 11:15AM  Too Far, Too Fast: 3 Stocks Ready To Fall TradingMarkets.com
06-Oct-09 12:29PM  Salix shares continue rising after Lupin deal AP
05-Oct-09 03:26PM  Salix Pharma in $5M licensing deal with Lupin AP
03:01PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Sta EDGAR Online
12:05PM  Salix in multimillion-dollar licensing deal with Lupin at bizjournals.com
10:57AM  Lupin Licenses US Rights for Proprietary Bioadhesive Technology for Rifaximin to Salix Pharmaceuticals PR Newswire
07:00AM  Salix Pharmaceuticals Acquires U.S. Right to Lupin's Proprietary Bioadhesive Technology for Extended Release Rifaximin Product Business Wire
29-Sep-09 02:13PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
11:06AM  Salix: Approval of Rifaximin Would Help Drive Long-Term Growth at Seeking Alpha
09:07AM  Rifaximin on track for New Indications Zacks.com
08:58AM  Metozolv ODT Launch on Track Zacks.com
28-Sep-09 05:33PM  [$$] SAC Capital Boosts Salix Stake to 9.9% at Barron's Online
11:15AM  Salix Pharmaceuticals to Present at JMP Securities Conference Business Wire
17-Sep-09 07:15AM  Psst... These Drug Firms Are Getting Bought: BioBuzz at TheStreet.com
15-Sep-09 02:05PM  Salix Scores on Rifaximin Data Zacks.com
14-Sep-09 09:07PM  [$$] Salix, Harry Winston and Perry Ellis Jump at The Wall Street Journal Online +51.12%
05:04PM  [$$] Stocks in the Spotlight Monday at Barron's Online
04:51PM  Patriot Coal, Salix Pharmaceuticals: Biggest Price Gainers (PCX, SLXP) at The Wall Street Journal Online
04:19PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
03:28PM  Stocks Claw Higher as Volatility Subsides at CNBC
03:00PM  US SMALL/MIDCAPS-Growth prospects boost healthcare companies at Reuters
02:02PM  Stocks Unfazed by Obama; Sprint Soars at CNBC
12:47PM  UPDATE - Salix Pharma's drug meets late-stage goals, shares soar at Reuters
12:42PM  Sprint Nextel, Salix Pharmaceuticals: Biggest Price Gainers (S, SLXP) at The Wall Street Journal Online
11:32AM  Salix shares jump on rifaximin study results AP
10:29AM  Stocks Slide as China Rift Rattles Market at CNBC
09:32AM  Salix says rifaximin met goal in IBS trials AP
07:08AM  Salix reports successful result in rifaximin trial at MarketWatch
07:03AM  UPDATE - Salix Pharma's bowel drug meets late-stage goals at Reuters
06:00AM  Salix Pharmaceuticals Announces Statistically Significant Results for Both the Primary and Key Secondary Analyses Of Rifaximin in the Treatment of Non-Constipation Irritable Bowel Syndrome in Two Phase 3 Trials (Target 1 and Target 2) Business Wire
11-Sep-09 10:06AM  Steel Partners Buys $3M Worth of Adaptec TheStreet.com
09-Sep-09 03:27PM  Good News for Salix Zacks.com
11:16AM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08-Sep-09 12:08PM  Salix says FDA approved stomach and heartburn drug AP
10:00AM  Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD Business Wire
03-Sep-09 02:59PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
02-Sep-09 07:00AM  Salix Pharmaceuticals to Present at Thomas Weisel Partners Conference Business Wire
26-Aug-09 11:20AM  Should You Hire A Job Search Firm? at Forbes.com
25-Aug-09 02:24PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
01:50PM  Salix Drug Gets Priority Status Zacks.com
11:05AM  FDA grants Salix drug rifaximin priority review at bizjournals.com
24-Aug-09 04:57PM  FDA grants Salix drug priority review AP
03:36PM  Salix Pharmaceuticals Announces FDA Acceptance for Filing and Priority Review Designation For Rifaximin NDA For the Maintenance of Remission of Hepatic Encephalopathy Business Wire
14-Aug-09 07:00PM  Smart Woman's Guide To Getting Hired at Forbes.com
11-Aug-09 09:27AM  New Star Analyst Rankings for Salix Pharmaceuticals, Ltd. StarMine
10-Aug-09 07:19PM  Salix 2Q loss doubles on research, sales expenses AP
05:01PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
05:00PM  Salix Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN
04:05PM  SALIX PHARMACEUTICALS LTD Files SEC form 10-Q, Quarterly Report EDGAR Online
04:01PM  Salix Pharmaceuticals Reports 2Q2009 Results Updates Full Year Guidance Business Wire
07:07AM  Q2 2009 Salix Pharmaceuticals, Inc. Earnings Release - After Market Close CCBN
30-Jul-09 02:54PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:32AM  Insiders Sell $31.8M Worth of Boston Properties at TheStreet.com
29-Jul-09 07:00AM  Salix Pharmaceuticals to Present at BMO Conference Business Wire
27-Jul-09 03:39PM  SALIX PHARMACEUTICALS LTD Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
07:00AM  Salix Pharmaceuticals Announces 2Q2009 Financial Results Conference Call and Webcast Business Wire
Salix Pharmaceuticals, Ltd., a specialty pharmaceutical company, engages in acquiring, developing, and commercializing prescription drugs used in the treatment of gastrointestinal disorders in the United States. Its products include Xifaxan tablet, a gastrointestinal-specific oral antibiotic for the treatment of patients with travelers' diarrhea; MoviPrep, a liquid polyethylene glycol-salt bowel cleansing product; Visicol and OsmoPrep tablets for cleansing of the colon as a preparation for colonoscopy in adults; and Azasan, a drug that suppresses immune system responses and is indicated for preventing rejection of kidney transplants and treatment of severe arthritis. The company also offers Anusol-HC and Proctocort, the hydrocortisone creams and suppositories for use in inflamed hemorrhoids and postirradiation proctitis, as well as an adjunct in the treatment of chronic ulcerative colitis and inflammatory conditions; Pepcid and Diuril oral suspensions, which are used for gastrointestinal indications that include the treatment of duodenal ulcer, benign gastric ulcer, and gastro esophageal reflux diseases; Apriso, for the maintenance of remission of ulcerative colitis in adults; and Colazal capsules for the treatment of ulcerative colitis. Salix Pharmaceuticals' products under development include Balsalazide Disodium tablets for ulcerative colitis; Crofelemer for HIV-associated diarrhea; Vapreotide acetate for acute esophageal variceal bleeding; and Metoclopramide-Zydis for the treatment of gastroesphageal reflux and gastroparesis. It has collaboration agreements with aaiPharma LLC; Alfa Wassermann S.P.A.; Biorex Laboratories Limited; CedarsSinai Medical Center; ALW Partnership; Debiopharm Group; Dr. Falk Pharma GmbH; King Pharmaceuticals, Inc.; Merck & Co., Inc.; Napo Pharmaceuticals, Inc.; Norgine B.V.; and Wilmington Pharmaceuticals, LLC. The company was founded in 1989 and is headquartered in Morrisville, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sirgo Mark ADirectorJan 15Buy27.092005,41836,706Jan 21 04:38 PM
Sirgo Mark ADirectorJan 06Buy27.892005,57836,506Jan 21 04:38 PM
Forbes William PV.P. Research& Devel & CDODec 23Sale25.005,000125,00062,762Dec 28 03:58 PM
LOGAN CAROLYN JPresident & CEODec 10Option Exercise1.1335,00039,550665,581Dec 14 05:03 PM
DERBYSHIRE ADAM CEVP Finance/CFODec 09Option Exercise1.135,0005,667113,371Dec 11 12:25 PM
DERBYSHIRE ADAM CEVP Finance/CFODec 09Sale23.105,000115,500108,371Dec 11 12:25 PM
DERBYSHIRE ADAM CEVP Finance/CFODec 02Option Exercise1.135,0005,667113,371Dec 02 04:55 PM
DERBYSHIRE ADAM CEVP Finance/CFODec 02Sale23.375,000116,850108,371Dec 02 04:55 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 25Option Exercise1.135,0005,667113,371Nov 30 12:55 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 25Sale23.585,000117,900108,371Nov 30 12:55 PM
Reeth Mark DGen Counsel&VP Corp ComplianceNov 23Sale23.643,37779,84948,562Nov 24 12:54 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 18Option Exercise1.135,0005,667113,371Nov 19 05:52 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 18Sale21.055,000105,250108,371Nov 19 05:52 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 11Option Exercise1.135,0005,667113,371Nov 13 04:09 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 11Sale20.125,000100,600108,371Nov 13 04:09 PM
DERBYSHIRE ADAM CEVP Finance/CFONov 04Option Exercise1.135,0005,667113,371Nov 06 09:46 AM
DERBYSHIRE ADAM CEVP Finance/CFONov 04Sale19.705,00098,489108,371Nov 06 09:46 AM
DERBYSHIRE ADAM CEVP Finance/CFOOct 28Option Exercise1.135,0005,667113,371Oct 29 03:01 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 28Sale19.795,00098,950108,371Oct 29 03:01 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 21Option Exercise1.135,0005,667113,371Oct 23 03:19 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 21Sale21.005,000105,000108,371Oct 23 03:19 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 14Option Exercise1.135,0005,667113,371Oct 14 03:46 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 14Sale22.895,000114,450108,371Oct 14 03:46 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 07Option Exercise1.135,0005,667113,371Oct 08 04:52 PM
DERBYSHIRE ADAM CEVP Finance/CFOOct 07Sale23.895,000119,450108,371Oct 08 04:52 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 30Option Exercise1.135,0005,667113,371Oct 01 03:57 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 30Sale21.045,000105,200108,371Oct 01 03:57 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 23Option Exercise1.135,0005,667113,371Sep 24 04:30 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 23Sale20.735,000103,650108,371Sep 24 04:30 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 16Option Exercise1.135,0005,667109,371Sep 16 04:34 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 16Sale19.805,00099,000108,371Sep 16 04:34 PM
LOGAN CAROLYN JPresident & CEOSep 14Option Exercise1.1310,00011,300640,581Sep 15 10:51 AM
LOGAN CAROLYN JPresident & CEOSep 14Sale20.6710,000206,742630,581Sep 15 10:51 AM
Flynn James EPossible Member of 10% GroupSep 10Sale13.13744,0609,773,0111,928,520Sep 10 06:46 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 09Option Exercise1.135,0005,667109,371Sep 09 04:56 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 09Sale12.925,00064,600108,371Sep 09 04:56 PM
Flynn James EPossible Member of 10% GroupSep 09Sale12.98170,7042,215,2383,437,936Sep 10 06:46 PM
Flynn James EPossible Member of 10% GroupSep 08Sale12.98111,1891,443,2333,608,640Sep 10 06:46 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 04Option Exercise1.131,0001,133109,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 04Sale12.451,00012,450108,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 03Option Exercise1.131,0001,133109,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 03Sale12.221,00012,222108,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 02Option Exercise1.131,0001,133109,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 02Sale12.011,00012,010108,371Sep 04 10:38 AM
DERBYSHIRE ADAM CEVP Finance/CFOSep 01Option Exercise1.131,0001,133109,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOSep 01Sale12.591,00012,594108,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 31Option Exercise1.131,0001,133109,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 31Sale12.501,00012,500108,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 28Option Exercise1.131,0001,133109,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 28Sale12.881,00012,880108,371Sep 01 05:55 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 27Option Exercise1.131,0001,133109,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 27Sale12.841,00012,839108,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 26Option Exercise1.131,0001,133109,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 26Sale12.701,00012,700108,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 25Option Exercise1.131,0001,133109,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 25Sale12.951,00012,950108,371Aug 27 04:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 24Option Exercise1.131,0001,133109,371Aug 24 04:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 24Sale12.621,00012,620108,371Aug 24 04:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 21Option Exercise1.131,0001,133109,371Aug 24 04:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 21Sale12.891,00012,890108,371Aug 24 04:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 20Option Exercise1.131,0001,133109,371Aug 24 04:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 20Sale12.701,00012,700108,371Aug 24 04:00 PM
Flynn James EPossible Member of 10% GroupAug 19Sale12.9810,921141,7553,719,829Aug 20 06:17 PM
Flynn James EPossible Member of 10% GroupAug 18Sale12.9670,000907,2003,730,750Aug 20 06:17 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 14Option Exercise1.131,0001,133109,371Aug 14 12:43 PM
Sirgo Mark ADirectorAug 14Buy12.4695011,84036,306Aug 17 06:04 PM
FRANCO RICHARD ADirectorAug 14Sale12.575,20065,36454,244Aug 18 04:28 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 14Sale12.661,00012,660108,371Aug 14 12:43 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 13Option Exercise1.131,0001,133109,371Aug 14 12:43 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 13Sale12.561,00012,564108,371Aug 14 12:43 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 12Option Exercise1.131,0001,133109,371Aug 14 12:43 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 12Sale12.591,00012,590108,371Aug 14 12:43 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 11Option Exercise1.131,0001,133109,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 11Sale12.601,00012,600108,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 10Option Exercise1.131,0001,133109,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 10Sale12.491,00012,490108,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 07Option Exercise1.131,0001,133109,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 07Sale12.331,00012,330108,371Aug 11 02:09 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 06Option Exercise1.131,0001,133109,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 06Sale12.511,00012,510108,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 05Option Exercise1.131,0001,133109,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 05Sale12.331,00012,330108,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 04Option Exercise1.131,0001,133109,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 04Sale12.101,00012,100108,371Aug 06 05:00 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 03Option Exercise1.131,0001,133109,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOAug 03Sale12.221,00012,220108,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 31Option Exercise1.131,0001,133109,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 31Sale12.271,00012,270108,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 30Option Exercise1.131,0001,133109,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 30Sale12.671,00012,670108,371Aug 03 05:32 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 29Option Exercise1.131,0001,133109,371Jul 29 05:02 PM
Flynn James EPossible Member of 10% GroupJul 29Sale12.559,901124,2582,176,124Jul 29 06:57 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 29Sale12.761,00012,760108,371Jul 29 05:02 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 28Option Exercise1.131,0001,133109,371Jul 29 05:02 PM
Flynn James EPossible Member of 10% GroupJul 28Sale12.9875,448979,3152,186,025Jul 29 06:57 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 28Sale12.991,00012,990108,371Jul 29 05:02 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 27Option Exercise1.131,0001,133109,371Jul 29 05:02 PM
Flynn James EPossible Member of 10% GroupJul 27Sale13.11144,2291,890,8422,261,473Jul 29 06:57 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 27Sale12.551,00012,550108,371Jul 29 05:02 PM
DERBYSHIRE ADAM CEVP Finance/CFOJul 24Option Exercise1.131,0001,133109,371Jul 24 01:08 PM
open in yahoo | open in reuters | open in google